CTC Alternative Strategies Ltd. Takes Position in Pfizer Inc. $PFE

CTC Alternative Strategies Ltd. purchased a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 219,860 shares of the biopharmaceutical company’s stock, valued at approximately $5,571,000. Pfizer accounts…